Vijaya Diagnost.

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE043W01024
  • NSEID: VIJAYA
  • BSEID: 543350
INR
1,018.50
-60.15 (-5.58%)
BSENSE

Dec 05

BSE+NSE Vol: 5.37 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Consolidate Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Net Sales
389.61
339.17
259.91
225.11
235.39
164.85
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
389.61
339.17
259.91
225.11
235.39
164.85
Raw Material Cost
45.73
41.75
30.64
29.69
37.32
26.85
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
63.87
55.20
42.67
39.22
33.24
27.08
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
124.65
105.00
81.11
67.57
56.83
45.79
Total Expenditure (Excl Depreciation)
234.25
201.95
154.42
136.48
127.39
99.72
Operating Profit (PBDIT) excl Other Income
155.36
137.22
105.49
88.63
108.00
65.13
Other Income
13.30
8.07
12.46
6.07
6.44
4.65
Operating Profit (PBDIT)
168.66
145.29
117.95
94.70
114.44
69.78
Interest
15.31
12.73
11.74
9.64
7.94
8.18
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
153.35
132.56
106.21
85.06
106.50
61.60
Depreciation
43.16
33.47
26.16
30.08
24.40
25.40
Profit Before Tax
110.19
99.09
80.05
54.99
82.10
36.21
Tax
28.32
25.46
20.09
13.97
20.78
7.81
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
81.87
73.63
59.96
41.02
61.32
28.40
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
81.87
73.63
59.96
41.02
61.32
28.40
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
-0.43
-0.25
-0.64
-0.06
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
81.87
73.63
59.53
40.78
60.68
28.33
Equity Capital
10.27
10.26
10.23
10.21
10.20
10.20
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
410.11
0.00
Earnings per share (EPS)
7.97
7.18
5.82
3.99
5.95
0.12
Diluted Earnings per share
7.95
7.15
5.81
3.98
5.91
2.78
Operating Profit Margin (Excl OI)
39.88%
40.46%
40.59%
39.37%
45.88%
39.51%
Gross Profit Margin
39.36%
39.08%
40.86%
37.79%
45.24%
37.37%
PAT Margin
21.01%
21.71%
23.07%
18.22%
26.05%
17.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 14.87% vs 30.50% in Sep 2024

stock-summary

Consolidate Net Profit

Growth in half year ended Sep 2025 is 11.19% vs 23.69% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 13.22% vs 30.08% in Sep 2024

stock-summary

Interest

Growth in half year ended Sep 2025 is 20.27% vs 8.43% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has fallen from Sep 2024

Compare Half Yearly Results Of Vijaya Diagnost. With
Markets Mojo
Figures in Cr
Consolidate Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
389.61
1,565.00
-1,175.39
-75.10%
Other Operating Income
0.00
0.00
0.00
Total Operating income
389.61
1,565.00
-1,175.39
-75.10%
Raw Material Cost
45.73
0.00
45.73
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
63.87
997.30
-933.43
-93.60%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
124.65
271.80
-147.15
-54.14%
Total Expenditure (Excl Depreciation)
234.25
1,269.10
-1,034.85
-81.54%
Operating Profit (PBDIT) excl Other Income
155.36
295.90
-140.54
-47.50%
Other Income
13.30
41.80
-28.50
-68.18%
Operating Profit (PBDIT)
168.66
337.70
-169.04
-50.06%
Interest
15.31
7.50
7.81
104.13%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
153.35
330.20
-176.85
-53.56%
Depreciation
43.16
45.00
-1.84
-4.09%
Profit Before Tax
110.19
285.20
-175.01
-61.36%
Tax
28.32
66.70
-38.38
-57.54%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
81.87
218.50
-136.63
-62.53%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
81.87
218.50
-136.63
-62.53%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
81.87
218.50
-136.63
-62.53%
Equity Capital
10.27
48.00
-37.73
-78.60%
Face Value
1.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
7.97
9.10
-1.13
-12.42%
Diluted Earnings per share
7.95
9.05
-1.10
-12.15%
Operating Profit Margin (Excl OI)
39.88%
18.91%
0.00
20.97%
Gross Profit Margin
39.36%
21.10%
0.00
18.26%
PAT Margin
21.01%
13.96%
0.00
7.05%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 389.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 14.87% vs 30.50% in Sep 2024

Half Yearly - Consolidate Net Profit
Consolidate Net Profit 81.87 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.19% vs 23.69% in Sep 2024

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 155.36 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 13.22% vs 30.08% in Sep 2024

Half Yearly - Interest
Interest 15.31 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 20.27% vs 8.43% in Sep 2024

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 39.88%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has fallen from Sep 2024